These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38927524)

  • 1. The Prognostic Value of Proliferative Activity in Cutaneous Melanoma: A Pilot Study Evaluating the Mitotic Rate and Ki67 Index to Predict Patient Outcomes.
    Tapoi DA; Gheorghișan-Gălățeanu AA; Gosman LM; Derewicz D; Costache M
    Biomedicines; 2024 Jun; 12(6):. PubMed ID: 38927524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I/II melanoma.
    Nielsen PS; Riber-Hansen R; Jensen TO; Schmidt H; Steiniche T
    Mod Pathol; 2013 Mar; 26(3):404-13. PubMed ID: 23174936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Clinical and Histopathological Factors on Disease Progression and Survival in Thick Cutaneous Melanomas.
    Țăpoi DA; Derewicz D; Gheorghișan-Gălățeanu AA; Dumitru AV; Ciongariu AM; Costache M
    Biomedicines; 2023 Sep; 11(10):. PubMed ID: 37892990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma.
    Gimotty PA; Van Belle P; Elder DE; Murry T; Montone KT; Xu X; Hotz S; Raines S; Ming ME; Wahl P; Guerry D
    J Clin Oncol; 2005 Nov; 23(31):8048-56. PubMed ID: 16258103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitotic rate is a more reliable unfavorable prognosticator than ulceration for early cutaneous melanoma: a 5-year survival analysis.
    Donizy P; Kaczorowski M; Leskiewicz M; Zietek M; Pieniazek M; Kozyra C; Halon A; Matkowski R
    Oncol Rep; 2014 Dec; 32(6):2735-43. PubMed ID: 25310673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate.
    McCall CM; Shi C; Cornish TC; Klimstra DS; Tang LH; Basturk O; Mun LJ; Ellison TA; Wolfgang CL; Choti MA; Schulick RD; Edil BH; Hruban RH
    Am J Surg Pathol; 2013 Nov; 37(11):1671-7. PubMed ID: 24121170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ki67 Proliferation Index as a Histopathological Predictive and Prognostic Parameter of Oral Mucosal Melanoma in Patients without Distant Metastases.
    Ma X; Wu Y; Zhang T; Song H; Jv H; Guo W; Ren G
    J Cancer; 2017; 8(18):3828-3837. PubMed ID: 29151970
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database.
    Thompson JF; Soong SJ; Balch CM; Gershenwald JE; Ding S; Coit DG; Flaherty KT; Gimotty PA; Johnson T; Johnson MM; Leong SP; Ross MI; Byrd DR; Cascinelli N; Cochran AJ; Eggermont AM; McMasters KM; Mihm MC; Morton DL; Sondak VK
    J Clin Oncol; 2011 Jun; 29(16):2199-205. PubMed ID: 21519009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center.
    Namikawa K; Aung PP; Gershenwald JE; Milton DR; Prieto VG
    Cancer Med; 2018 Mar; 7(3):583-593. PubMed ID: 29464914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acral lentiginous melanoma: histopathological prognostic features of 121 cases.
    Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
    Br J Dermatol; 2007 Aug; 157(2):311-8. PubMed ID: 17596173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 Cases.
    Nagarajan P; Curry JL; Ning J; Piao J; Torres-Cabala CA; Aung PP; Ivan D; Ross MI; Levenback CF; Frumovitz M; Gershenwald JE; Davies MA; Malpica A; Prieto VG; Tetzlaff MT
    Clin Cancer Res; 2017 Apr; 23(8):2093-2104. PubMed ID: 27864417
    [No Abstract]   [Full Text] [Related]  

  • 12. PRAME expression in cutaneous melanoma does not correlate with disease-specific survival.
    Parra O; Ma W; Li Z; Coffing BN; Linos K; LeBlanc RE; Momtahen S; Sriharan A; Cloutier JM; Wells WA; Yan S
    J Cutan Pathol; 2023 Oct; 50(10):903-912. PubMed ID: 37430414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathological evaluation of cutaneous malignant melanoma: A retrospective study.
    Gheoca Mutu DE; Avino A; Balcangiu-Stroescu AE; Mehedințu M; Bălan DG; Brîndușe LA; Popescu AM; Ionescu D; Cristea BM; Tomescu LF; Jecan CR; Răducu L
    Exp Ther Med; 2022 Jun; 23(6):402. PubMed ID: 35601077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
    Massi D; Borgognoni L; Franchi A; Martini L; Reali UM; Santucci M
    Melanoma Res; 2000 Apr; 10(2):153-64. PubMed ID: 10803716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic importance of the mitotic marker phosphohistone H3 in cutaneous nodular melanoma.
    Ladstein RG; Bachmann IM; Straume O; Akslen LA
    J Invest Dermatol; 2012 Apr; 132(4):1247-52. PubMed ID: 22297638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitotic rate as an important prognostic factor in cutaneous malignant melanoma.
    Piñero-Madrona A; Ruiz-Merino G; Cerezuela Fuentes P; Martínez-Barba E; Rodríguez-López JN; Cabezas-Herrera J
    Clin Transl Oncol; 2019 Oct; 21(10):1348-1356. PubMed ID: 30783917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in localized invasive cutaneous melanoma: high value of mitotic rate, vascular invasion and microscopic satellitosis.
    Nagore E; Oliver V; Botella-Estrada R; Moreno-Picot S; Insa A; Fortea JM
    Melanoma Res; 2005 Jun; 15(3):169-77. PubMed ID: 15917698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipophilin expression in cutaneous malignant melanoma is associated with high proliferation and poor clinical prognosis.
    Fujimoto M; Matsuzaki I; Nishitsuji K; Yamamoto Y; Murakami D; Yoshikawa T; Fukui A; Mori Y; Nishino M; Takahashi Y; Iwahashi Y; Warigaya K; Kojima F; Jinnin M; Murata SI
    Lab Invest; 2020 May; 100(5):727-737. PubMed ID: 31857696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of P53 protein overexpression, Ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder.
    Gontero P; Casetta G; Zitella A; Ballario R; Pacchioni D; Magnani C; Muir GH; Tizzani A
    Eur Urol; 2000 Sep; 38(3):287-96. PubMed ID: 10940702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic evaluation of Ki67 threshold value in canine oral melanoma.
    Bergin IL; Smedley RC; Esplin DG; Spangler WL; Kiupel M
    Vet Pathol; 2011 Jan; 48(1):41-53. PubMed ID: 21123859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.